ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OXN Oxonica

3.125
0.00 (0.00%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Oxonica LSE:OXN London Ordinary Share GB00B0D09P49 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.125 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Annual Financial Report

03/06/2009 3:47pm

UK Regulatory



 

TIDMOXN 
 
RNS Number : 3159T 
Oxonica plc 
03 June 2009 
 

 
 
3 June 2009 
 
 
Oxonica plc 
 
 
Annual Report & Accounts and Notice of Annual General Meeting 
 
 
 
 
 
The Company's Annual Report and Financial Statements for the year to 31 December 
2008 were posted to our shareholders on Friday 8th May together with Notice of 
the Annual General Meeting, which is to be held in the Oxford Room, 
Begbroke Science Park, Yarnton, Oxford, at 11am on Thursday 18th June 2009. 
 
 
Copies are available for inspection free of charge at our registered office at 
7 Begbroke Science Park, Sandy Lane, Yarnton, Kidlington, Oxfordshire, OX5 1PF 
and from our website at www.oxonica.com. 
 
 
 
 
For further information, please contact: 
 
 
Oxonica plc 01865 856 700 
Kevin Matthews, Chief Executive 
Richard Clarke, Finance Director 
 
 
Panmure Gordon  020 7459 3600 
Hugh Morgan 
Andrew Potts 
 
 
 
 
 
 
 
 
 
 
Notes to Editors 
 
 
About Oxonica plc - www.oxonica.com 
 
 
Oxonica (AIM: OXN.L) is a leading nanomaterials group with products already 
launched into international markets. Oxonica's mission is to focus on the 
commercialisation of innovative products using its expertise in the design and 
application of nanomaterials. 
 
Lead products include: 
  *  Envirox(TM) Fuel Borne Catalyst - a nanocatalyst improving fuel economy 
  and reducing emissions 
  *  Optisol(TM) UV absorber - a photostable UV protection system designed to 
  optimise the performance of quality sunscreens and anti-premature aging products 
 
 
The Group also generates licence and development revenue from activities in the 
clinical diagnostics and security markets. 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 ACSILFSSREIVIIA 
 

1 Year Oxonica Chart

1 Year Oxonica Chart

1 Month Oxonica Chart

1 Month Oxonica Chart